Experimental pancreatic cancer drug offers new hope in major trial
Experimental pancreatic cancer drug offers new hope in major trial ABC7 Los Angeles
Онкология
Исследования и наука
1140 материалов по теме, собраны автоматически из проверенных источников
Онкология
Three-Year Overall Survival Reaches 48% in Recurrent Ovarian Cancer Study – Agenus
Three-Year Overall Survival Reaches 48% in Recurrent Ovarian Cancer Study – Agenus Oncodaily
Онкология
Transforming GI Cancer Research Into Practice – Society of Surgical Oncology
Transforming GI Cancer Research Into Practice – Society of Surgical Oncology Oncodaily
Онкология
This common vitamin could help fight one of the deadliest brain cancers
High-dose vitamin B3 is showing intriguing early promise as an addition to standard glioblastoma treatment, with 82% of patients in a small trial remaining progression-free after six months. Researchers believe niacin may help revive immune cells suppressed by the cancer, but larger studies are still needed to confirm…
🎗️
Онкология
KCRF awards three scholarships and 20K grant for cancer research - pmg-ky1.com
KCRF awards three scholarships and 20K grant for cancer research pmg-ky1.com
Онкология
NCI Pancreatic Cancer Detection Consortium: Research Units
NCI Pancreatic Cancer Detection Consortium: Research Units Oncodaily
Онкология
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Oncodaily
Онкология
Vitamin D drug may help crack pancreatic cancer’s protective shield
A vitamin D analog may help break down pancreatic cancer’s protective defenses, potentially making tumors more vulnerable to chemotherapy and immune attack. A small clinical trial found encouraging responses, especially in patients whose tumors had high levels of the vitamin D receptor.
Онкология
FY26 Peer Reviewed Cancer Research Program (PRCRP) Idea Award
FY26 Peer Reviewed Cancer Research Program (PRCRP) Idea Award oncodaily.com
Онкология
Genmab A/S reports 45.9% Rina‑S response in ovarian cancer trial
Genmab A/S reports 45.9% Rina‑S response in ovarian cancer trial Mugglehead Investment Magazine
Онкология
Are You Helping Shape How AI Is Implemented in Clinical Trial Operations? - Sylvester Comprehensive Cancer Center
Are You Helping Shape How AI Is Implemented in Clinical Trial Operations? - Sylvester Comprehensive Cancer Center Oncodaily
Онкология
Anirban Maitra: KRAS-X Brings Together Clinical and Translational Research in Solid Cancers
Anirban Maitra: KRAS-X Brings Together Clinical and Translational Research in Solid Cancers Oncodaily
🎗️
Онкология
Rare Aggressive Sarcoma Shows Surprising Sensitivity to Targeted Small Molecules in New Lab Study
Rare Aggressive Sarcoma Shows Surprising Sensitivity to Targeted Small Molecules in New Lab Study Bioengineer.org
Онкология
Study: Sex chromosomes drive how bodies deal with cancer, heart health and longevity
Study: Sex chromosomes drive how bodies deal with cancer, heart health and longevity University of Arizona News
Онкология
Julie Gralow: Advancing Cancer Care and Clinical Trials Through Global Partnership
Julie Gralow: Advancing Cancer Care and Clinical Trials Through Global Partnership Oncodaily